Canadian application, no grantCanada
Hybrid cell vaccines
CA 2400636 A1 · Owner: Kanz, Lothar · Inventors: Walden, Peter; Stuhler, Gernot; Kanz, Lothar
Overview
Drawings and full text
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to methods and compositions for treating and preventing cancer and infectious disease using hybrid cells formed by fusion of allogeneic dendritic cells and autologous non-dendritic cells.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 20, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 20, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 20, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledMarch 20, 2000
GrantedNo grant recorded
Term endedMarch 20, 2020
Patent numberCA 2400636 A1
Classification (IPC)C12N5/16 +2 more
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.